HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

A seven days course of eflornithine for relapsing Trypanosoma brucei gambiense sleeping sickness.

Abstract
Forty-seven patients with a relapse following a first treatment of Trypanosoma brucei gambiense trypanosomiasis were treated with a 7 d course of intravenous eflornithine (100 mg/kg every 6 h) and followed for 2 years. Four patients died after treatment, 2 of them possibly due to trypanosomiasis. One patient was completely lost to follow-up, 36 were followed for at least one year, and 25 have completed the 2 years' follow-up. Only one patient, a 5 years old child, subsequently relapsed. Considering this child and 2 of the fatalities as treatment failures, the rate of failure was 6.5%. A 7 d course of intravenous eflornithine is an adequate treatment for cases of Gambian trypanosomiasis relapsing after treatment with another drug.
AuthorsN Khonde, J Pépin, B Mpia
JournalTransactions of the Royal Society of Tropical Medicine and Hygiene (Trans R Soc Trop Med Hyg) 1997 Mar-Apr Vol. 91 Issue 2 Pg. 212-3 ISSN: 0035-9203 [Print] ENGLAND
PMID9196773 (Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Trypanocidal Agents
  • Eflornithine
Topics
  • Adolescent
  • Adult
  • Aged
  • Animals
  • Child
  • Child, Preschool
  • Drug Administration Schedule
  • Eflornithine (administration & dosage, therapeutic use)
  • Female
  • Follow-Up Studies
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Middle Aged
  • Recurrence
  • Treatment Failure
  • Trypanocidal Agents (administration & dosage, therapeutic use)
  • Trypanosoma brucei gambiense
  • Trypanosomiasis, African (cerebrospinal fluid, drug therapy, parasitology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: